ONLINE PRESENTATION
Vaccine Research: What It’s All About?
Joseph Payne, Arcturus Therapeutics

PLEASE NOTE CORRECTED DATE: Thursday, November 19, 2020, 7:30 p.m. MST

What protocols are involved in the different phases of vaccine research and development?

What are the challenges involved in producing, storing and shipping millions of doses of vaccine?

At a time when the world is eagerly awaiting a COVID-19 vaccine, join us for an insider’s peek into the therapeutics industry. Joseph Payne from Arcturus Therapeutics will talk to us about vaccine research, guidelines, getting a vaccine to market, as well as pandemic, endemic and maintenance phases of vaccine protocols. A Q&A session will follow the presentation.

This event will be presented online and is free of charge to those who have a current 2020 UCPBA Calgary membership. Non-member cost is $25. Please RSVP to admin@ucpbacalgary.org or CLICK HERE to pay. Registered participants will receive a link to the event.

*****

Joseph Payne is President and CEO of Arcturus Therapeutics, based in San Diego, California.  Originally from Calgary, Joe brings with him an exceptional track record of ushering novel therapeutics to the clinic, including targeted RNA medicines utilizing lipid-mediated delivery technologies. Joseph’s background includes over 20 years of successful drug discovery experience at Merck Research Labs, DuPont Pharmaceuticals, Bristol-Myers Squibb, Kalypsys, and Nitto, as evidenced by over 40 publications and patents, and several investigational new drug (IND) clinical candidates. His academic training includes a Bachelor’s Degree in Chemistry, magna cum laude from Brigham Young University, a Master of Science in Synthetic Organic Chemistry from the University of Calgary and Executive Training Certification from MIT Sloan School of Management.

Arcturus Therapeutics is one of over 150 companies worldwide working on a vaccine for COVID-19.